丸美生物
(603983)
| 流通市值：100.93亿 | | | 总市值：100.93亿 |
| 流通股本：4.01亿 | | | 总股本：4.01亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,303,293,421.55 | 1,250,410,466.65 | 1,591,921,263.21 | 1,672,805,988.45 |
| 交易性金融资产 | 355,941,650.31 | 388,664,951.42 | 412,622,657.55 | 390,511,396.59 |
| 应收票据及应收账款 | 29,509,238.21 | 36,742,862.44 | 20,406,964.01 | 25,466,199.58 |
| 应收账款 | 29,509,238.21 | 36,742,862.44 | 20,406,964.01 | 25,466,199.58 |
| 应收款项融资 | 1,988,500 | 1,660,500 | 1,691,250 | 922,500 |
| 预付款项 | 153,255,717.76 | 51,654,293.75 | 96,371,057.48 | 81,540,610.04 |
| 其他应收款合计 | 6,956,473.97 | 22,115,782.96 | 12,458,279.65 | 12,164,012.69 |
| 存货 | 224,621,581.14 | 233,349,706.97 | 281,372,130.76 | 241,104,451.2 |
| 一年内到期的非流动资产 | 54,127,671.23 | 53,745,479.45 | 53,354,794.52 | - |
| 其他流动资产 | 183,764,465.55 | 197,543,195.79 | 123,883,379.16 | 135,101,028.4 |
| 流动资产合计 | 2,313,458,719.72 | 2,235,887,239.43 | 2,594,081,776.34 | 2,559,616,186.95 |
| 非流动资产: | | | | |
| 长期应收款 | - | - | - | 638,711 |
| 长期股权投资 | 240,675,148.09 | 240,674,838.88 | 226,223,585.42 | 180,465,729.74 |
| 投资性房地产 | 630,659,339.62 | 608,261,766.29 | 211,932,514.54 | 186,457,039.67 |
| 固定资产 | 885,543,558.27 | 906,221,734.05 | 996,677,200.89 | 956,591,209.69 |
| 在建工程 | 19,925,856.06 | 22,886,909.61 | 19,068,806.7 | 27,594,774.41 |
| 使用权资产 | 2,465,715.96 | 2,658,343.16 | 2,724,606.9 | 1,145,318.24 |
| 无形资产 | 390,927,767.83 | 394,152,331.03 | 688,488,832.43 | 690,215,398.29 |
| 长期待摊费用 | 25,199,314.86 | 21,233,632.89 | 7,982,034.64 | 12,310,027.51 |
| 递延所得税资产 | 109,111,263.65 | 110,829,131.25 | 90,408,654.07 | 85,973,531.71 |
| 其他非流动资产 | 72,333,720.1 | 70,648,900.44 | 9,034,847.18 | 57,337,089.55 |
| 非流动资产合计 | 2,376,841,684.44 | 2,377,567,587.6 | 2,252,541,082.77 | 2,198,728,829.81 |
| 资产总计 | 4,690,300,404.16 | 4,613,454,827.03 | 4,846,622,859.11 | 4,758,345,016.76 |
| 流动负债: | | | | |
| 短期借款 | 467,000,000 | 395,000,000 | 572,990,000 | 547,990,000 |
| 应付票据及应付账款 | 293,365,747.68 | 315,677,304.82 | 210,968,699.28 | 368,953,166.69 |
| 应付账款 | 293,365,747.68 | 315,677,304.82 | 210,968,699.28 | 368,953,166.69 |
| 合同负债 | 180,930,194.86 | 184,817,793.41 | 176,365,461.37 | 177,109,148.25 |
| 应付职工薪酬 | 21,467,735.77 | 32,803,255.29 | 26,152,975.51 | 17,161,496.55 |
| 应交税费 | 49,045,398 | 37,207,296.05 | 29,643,306.16 | 41,315,985.78 |
| 其他应付款合计 | 151,307,803.13 | 210,291,719.15 | 403,504,216.16 | 152,300,186.85 |
| 应付股利 | - | - | 100,250,000 | - |
| 一年内到期的非流动负债 | 837,154.57 | 828,228.07 | 1,059,788.03 | 788,427.69 |
| 其他流动负债 | 13,251,412.11 | 22,182,401.75 | 16,147,822.46 | 17,044,655.63 |
| 流动负债合计 | 1,177,205,446.12 | 1,198,807,998.54 | 1,436,832,268.97 | 1,322,663,067.44 |
| 非流动负债: | | | | |
| 租赁负债 | 1,778,282.19 | 1,982,749.21 | 1,925,368.01 | 419,791.07 |
| 递延收益 | 4,172,440.99 | 4,238,130.94 | 4,752,289.43 | 4,964,251.55 |
| 递延所得税负债 | 14,567,380.7 | 14,250,703.47 | 11,826,927.02 | 10,737,799.86 |
| 非流动负债合计 | 20,518,103.88 | 20,471,583.62 | 18,504,584.46 | 16,121,842.48 |
| 负债合计 | 1,197,723,550 | 1,219,279,582.16 | 1,455,336,853.43 | 1,338,784,909.92 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 401,000,000 | 401,000,000 | 401,000,000 | 401,000,000 |
| 资本公积 | 765,281,532.15 | 765,281,532.15 | 760,997,417.99 | 760,997,417.99 |
| 其他综合收益 | -1,755,167.67 | -1,730,778.52 | -1,781,619.5 | -1,820,648.73 |
| 盈余公积 | 200,909,800 | 200,909,800 | 200,909,800 | 200,909,800 |
| 未分配利润 | 2,066,717,312.63 | 1,965,697,348.25 | 1,962,350,461.48 | 1,993,118,851.83 |
| 归属于母公司股东权益合计 | 3,432,153,477.11 | 3,331,157,901.88 | 3,323,476,059.97 | 3,354,205,421.09 |
| 少数股东权益 | 60,423,377.05 | 63,017,342.99 | 67,809,945.71 | 65,354,685.75 |
| 股东权益合计 | 3,492,576,854.16 | 3,394,175,244.87 | 3,391,286,005.68 | 3,419,560,106.84 |
| 负债和股东权益合计 | 4,690,300,404.16 | 4,613,454,827.03 | 4,846,622,859.11 | 4,758,345,016.76 |
| 公告日期 | 2026-04-30 | 2026-04-01 | 2025-10-31 | 2025-08-23 |
| 审计意见(境内) | | 标准无保留意见 | | |